Elejalde syndrome

From WikiMD's Medical Encyclopedia

Revision as of 05:18, 16 February 2025 by Prab (talk | contribs) (CSV import)

Elejalde Syndrome

Diagram of autosomal recessive inheritance pattern

Elejalde syndrome, also known as neuroectodermal melanolysosomal disease, is a rare genetic disorder characterized by a combination of neurological, dermatological, and ocular abnormalities. It is an autosomal recessive condition, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to be affected by the disorder.

Clinical Features

Individuals with Elejalde syndrome typically present with a range of symptoms that can vary in severity. Common clinical features include:

Pathophysiology

Elejalde syndrome is caused by mutations in genes involved in the development and function of melanosomes, which are specialized organelles responsible for the production and storage of melanin. The exact genetic mutations responsible for Elejalde syndrome have not been fully elucidated, but they are believed to affect the lysosomal and melanosomal pathways.

Diagnosis

Diagnosis of Elejalde syndrome is primarily based on clinical evaluation and the identification of characteristic symptoms. Genetic testing can confirm the diagnosis by identifying mutations in the relevant genes. Differential diagnosis may include other conditions with similar presentations, such as Chediak-Higashi syndrome and Griscelli syndrome.

Management

There is currently no cure for Elejalde syndrome, and treatment is primarily supportive. Management strategies may include:

  • Neurological care: Anticonvulsant medications may be used to control seizures.
  • Dermatological care: Sun protection and skin care may be recommended to manage hypopigmentation.
  • Ophthalmological care: Regular eye examinations and corrective lenses may be necessary to address vision problems.

Genetic Counseling

Genetic counseling is recommended for families affected by Elejalde syndrome. As an autosomal recessive disorder, there is a 25% chance with each pregnancy that two carrier parents will have an affected child. Carrier testing and prenatal diagnosis may be options for at-risk families.

Related Pages

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes


Ad. Transform your life with W8MD's

GLP-1 weight loss injections special from $29.99 with insurance

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.